Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum

被引:33
|
作者
Subehan
Usia, Tepy
Kadota, Shigetoshi
Tezuka, Yasuhiro [1 ]
机构
[1] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan
[2] Toyama Univ, 21st Century COE Program, Toyama 9300194, Japan
关键词
Piper nigrum; alkamides; cytochrome P450 2D6; CYP2D6; mechanism-based inhibition; drug-herb interaction;
D O I
10.1055/s-2006-931558
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Nineteen alkamides isolated from Piper nigrum L. were tested for their mechanism-based inhibition on human liver microsomal dextromethorphan O-demethylation activity, a prototype marker for cytochrome P450 2D6 (CYP2D6). All compounds increased their inhibitory activity with increasing preincubation time. Among them, 15 and 17 showed more than 50% decrease of the CYP2D6 residual activity after 20 min preincubation. Further investigations on 15 and 17 showed that the characteristic time and concentration-dependent inhibition, which required a catalytic step with NADPH, was not protected by nucleophiles, and was decreased by the presence of a competitive inhibitor. The kinetic. parameters for inactivation (k(inact) and k(I)) were 0.028 min(-1) and 0.23 mu M for 15 and 0.064 min(-1) and 0.71 mu M for 17, respectively, which were stronger than the known mechanism-based inhibitor, paroxetine (a positive control). Thus, 15 and 17 are potent mechanism-based inhibitors of CYP2D6.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 50 条
  • [32] Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population
    Salyakina, Daria
    Roy, Sharmeen
    Wang, Weize
    Oliva, Mailin
    Akhouri, Rohan
    Sotto, Ileana
    Mulas, Nicole
    Solano, Rafaela
    Fernandez, Jose R.
    Sanchez, Stephanie
    Shamshad, Uzma
    Perlyn, Chad
    McCafferty-Fernandez, Jennifer
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (09):
  • [33] Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects
    Gaedigk, A
    Ndjountché, L
    Gaedigk, R
    Leeder, JS
    Bradford, LD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) : 575 - 576
  • [34] Crystal structure of human cytochrome P450 2D6
    Rowland, P
    Blaney, FE
    Smyth, MG
    Jones, JJ
    Leydon, VR
    Oxbrow, AK
    Lewis, CJ
    Tennant, MG
    Modi, S
    Eggleston, DS
    Chenery, RJ
    Bridges, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7614 - 7622
  • [35] MECHANISM-BASED INACTIVATION OF CYTOCHROME P450 2D6 BY BERBERINE ISOLATED FROM COPTIS JAPONICA
    Kim, Min-Jung
    DRUG METABOLISM REVIEWS, 2014, 45 : 114 - 114
  • [36] Mechanism-based inhibition of CYP2D6 by paroxetine.
    Bertelsen, KM
    Venkatakrishnan, K
    von Moltke, LL
    Obach, RS
    Greenblatt, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P77 - P77
  • [37] Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine
    Madadi, Parvaz
    Ciszkowski, Catherine
    Gaedigk, Andrea
    Leeder, J. Steven
    Teitelbaum, Ronni
    Chitayat, David
    Koren, Gideon
    CURRENT DRUG SAFETY, 2011, 6 (01) : 36 - 39
  • [38] Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)
    Desta, Z
    Kerbusch, T
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 10 - 20
  • [39] Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results
    Druid, H
    Holmgren, P
    Carlsson, B
    Ahlner, J
    FORENSIC SCIENCE INTERNATIONAL, 1999, 99 (01) : 25 - 34
  • [40] Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent
    Loeper, J
    Louérat-Oriou, B
    Duport, C
    Pompon, D
    MOLECULAR PHARMACOLOGY, 1998, 54 (01) : 8 - 13